US2009156831A1PendingUtilityA1
Processes for preparing darifenacin hydrobromide
Est. expiryDec 27, 2025(expired)· nominal 20-yr term from priority
C07D 207/48C07D 207/09C07D 405/06C07D 307/79A61P 13/00
68
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention encompasses processes for the preparation of darifenacin hydrobromide.
Claims
exact text as granted — not AI-modified1 . A process for preparing darifenacin hydrobromide, comprising converting N-protected-3-(S)-pyrrolidinol of the formula
into darifenacin hydrobromide, wherein X is S, SO 2 , Si, or CO, and R is phenyl, tolyl, ortho, meta, or para-xylyl, linear or branched C 1-10 alkyl, H, or CF 3 .
2 . The process according to claim 1 , wherein the conversion comprises preparing 1-X-sulfonyl-3-(S)-(−)-X-sulfonyloxypyrrolidine of formula I
in a process comprising combining 3-(S)-(+)-hydroxypyrrolidine, a sulfonyl halide, a base, and a solvent selected from the group consisting of a C 6-9 aromatic hydrocarbon, a polar aprotic organic solvent, and mixtures thereof to obtain 1-X-sulfonyl-3-(S)-(−)-X-sulfonyloxypyrrolidine, wherein X is either C 1-10 alkyl or C 6-9 aryl.
3 . The process of claim 2 , wherein X is tolyl.
4 . The process of claim 2 , wherein the solvent is selected from a group consisting of C 6-9 aromatic hydrocarbon, C 1-10 halogenated aliphatic hydrocarbon, amide, sulfoxide, and mixtures thereof.
5 . The process of claim 4 , wherein the solvent is selected from a group consisting of toluene, o-xylene, m-xylene, p-xylene, dichloromethane, 1,2-dichloroethane, dichloropentane, dimethylformamidem Dimethylacetamide, dimethylsulfoxide, and mixtures thereof.
6 . The process of claim 2 , wherein the process, further comprises a phase transfer catalyst.
7 . The process of claim 6 , wherein the phase transfer catalyst is selected from the group consisting of tetrabutylammonium bromide, tributylmethylammonium chloride, tetrabutylammonium sulfate, and dimethylsulfoxide.
8 . The process of claim 2 , wherein the halide moiety of the sulfonyl halide is selected from chloride, bromide, and iodide.
9 . The process of claim 8 , wherein the sulfonyl halide is tosylchloride, mesylchloride, or brosylchloride.
10 . The process of claim 2 , wherein the base is an organic base.
11 . The process of claim 10 , wherein the organic base is selected from the group consisting of aliphatic and aromatic amines.
12 . The process of claim 11 , wherein the organic base is selected from a group consisting of triethylamine, methylmorpholine, N,N-diisopropylethyl amine, pyridine and mixtures thereof.
13 . The process of claim 2 , wherein the base is an inorganic base.
14 . The process of claim 13 , wherein the inorganic base is an alkali base.
15 . The process of claim 14 , wherein the alkali base is sodium hydroxide or potassium hydroxide.
16 . The process of claim 2 , further comprising recovering the 1-X-sulfonyl-3-(S)-(−)-X-sulfonyloxypyrrolidine.
17 . The process according to claim 1 , wherein the conversion comprises preparing (S)-2,2-diphenyl-2-(1-X-sulfonyl-3-pyrrolidinil) acetonitrile of formula II
in a process comprising combining 1-X-sulfonyl-3-(S)-(−)-X-sulfonyloxypyrrolidine of formula I,
diphenylacetonitrile, and an inorganic base in an organic solvent selected from the group consisting of a C 6-9 aromatic hydrocarbon, a polar aprotic organic solvent, and mixtures thereof, and an inorganic base to obtain (S)-2,2-diphenyl-2-(1-X-sulfonyl-3-pyrrolidinil)acetonitrile, wherein X is either C 1-10 alkyl or C 6-9 aryl.
18 . The process of claim 17 , wherein X is tolyl.
19 . The process of claim 17 , wherein the solvent is selected from a group consisting of C 6-9 aromatic hydrocarbon, amide, and sulfoxide.
20 . The process of claim 19 , wherein the solvent is selected from a group consisting of C 1-2 amide, dimethylformamide, dimethylacetamide, C 1-4 sulfoxide, dimethylsulfoxide and mixtures thereof.
21 . The process of claim 17 , wherein the inorganic base is a metal alkoxide or an alkali hydroxide.
22 . The process of claim 21 , wherein the inorganic base is selected from a group consisting of sodium tert-butoxide, potassium tert-butoxide, sodium methoxide, sodium hydroxide, and potassium hydroxide.
23 . The process of claim 17 , further comprising recovering the (S)-2,2-diphenyl-2-(1-X-sulfonyl-3-pyrrolidinil)acetonitrile.
24 . The process according to claim 1 , wherein the conversion comprises preparing 3-(S)-(+)-(1-carbamoyl-1,1-diphenylmethyl)pyrrolidine tartrate of formula VI
in a process comprising:
a. combining (S)-2,2-diphenyl-2-(3-pyrrolidinil) acetonitrile salt of formula III,
a solvent selected from the group consisting of a water immiscible organic solvent, a polar aprotic organic solvent, water, and mixtures thereof, and an inorganic base to form a mixture;
b. acidifying the mixture;
c. heating the mixture;
d. basifying the mixture; and
e. combining the mixture with a C 1-4 alcohol and L-tartaric acid to obtain 3-(S)-(+)-(1-carbamoyl-1,1-diphenylmethyl)pyrrolidine tartrate,
wherein Z1 is an acid.
25 . The process of claim 24 , wherein Z 1 is HBr or HCl.
26 . The process of claim 24 , wherein the (S)-2,2-diphenyl-2-(3-pyrrolidinil)acetonitrile salt of formula III is converted into the free base of formula XI
prior to step b).
27 . The process of claim 26 , wherein the (S)-2,2-diphenyl-2-(3-pyrrolidinil)acetonitrile salt of formula III is converted into the free base of formula XI by combining the (S)-2,2-diphenyl-2-(3-pyrrolidinil)acetonitrile salt of formula III a solvent selected from the group consisting of water immiscible organic solvents, a polar aprotic organic solvent, water, and mixtures thereof, and an inorganic base.
28 . The process of claim 24 , wherein the solvent is selected from a group consisting of C 6-9 aromatic hydrocarbon, water, C 1-10 halogenated aliphatic hydrocarbon, ester, and mixtures thereof.
29 . The process of claim 28 , wherein the solvent is selected from a group consisting of toluene, xylenes, isopropylbenzene, styrene, water, dichloromethane, 2-dichloroethane, 1,1,-dichloroethane, 1,5-dichloropentane, ethyl acetate and mixtures thereof.
30 . The process of claim 28 , wherein the solvent is a mixture of a C 1-10 halogenated aliphatic hydrocarbon and water.
31 . The process of claim 30 , wherein the C 1-10 halogenated aliphatic hydrocarbon is dichloromethane.
32 . The process of claim 24 , wherein the acidifying comprises adding an acid to the mixture and heating the mixture.
33 . The process of claim 32 , wherein the strong mineral acid is sulphuric acid or phosphoric acid.
34 . The process of claim 32 , wherein the mixture is heated to a temperature of about 80° C. to about 110° C.
35 . The process of claim 24 , wherein the mixture is basified to a pH of about 10 to about 13.
36 . The process of claim 24 , wherein the mixture is basified by adding an inorganic base.
37 . The process of claim 36 , wherein the inorganic base is an aqueous solution of an alkali base.
38 . The process of claim 37 , wherein the alkali base is selected from a group consisting of sodium hydroxide, potassium hydroxide sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate and mixtures thereof.
39 . The process of claim 24 , wherein the C 1-4 alcohol is methanol, ethanol, isopropanol, or n-butanol.
40 . The process of claim 24 , further comprising recovering the 3-(S)-(+)-(1-carbamoyl-1,1-diphenylmethyl)pyrrolidine tartrate of formula VI.
41 . A process for preparing darifenacin hydrobromide comprising:
a) combining 3-(S)-(+)-hydroxypyrrolidine, a solvent selected from the group consisting of a C 6-9 aromatic hydrocarbon, a polar aprotic organic solvent, and mixtures thereof, a sulfonyl halide, and a base to obtain 1-X-sulfonyl-3-(S)-(−)-X-sulfonyloxypyrrolidine of formula I,
b) reacting the 1-X-sulfonyl-3-(S)-(−)-X-sulfonyloxypyrrolidine of formula I with diphenylacetonitrile and an inorganic base in an organic solvent selected from the group consisting of a C 6-9 aromatic hydrocarbon, a polar aprotic organic solvent, and mixtures thereof to obtain (S)-2,2-diphenyl-2-(1-X-sulfonyl-3-pyrrolidinil)acetonitrile of formula II;
c) reacting the (S)-2,2-diphenyl-2-(1-X-sulfonyl-3-pyrrolidinil) acetonitrile intermediate of formula II with a bromine acceptor selected from the group consisting of phenol and naphthol and an acid to obtain (S)-2,2-diphenyl-2-(3-pyrrolidinil) acetonitrile salt of formula III,
wherein the bromine acceptor is phenol only when the acid is HBr;
d) combining the (S)-2,2-diphenyl-2-(3-pyrrolidinil) acetonitrile salt of formula III and an inorganic base with a solvent selected from the group consisting of water immiscible organic solvent, a polar aprotic organic solvent, water, and mixtures thereof to form a mixture;
e) acidifying the mixture;
f) heating the mixture
g) basifying the mixture;
h) combining the mixture with a C 1-4 alcohol and L-tartaric acid to obtain 3-(S)-(+)-(1-carbamoyl-1,1-diphenylmethyl)pyrrolidine tartrate of formula VI;
i) converting 3-(S)-(+)-(1-carbamoyl-1,1-diphenylmethyl)pyrrolidine tartrate of formula VI to Darifenacin hydrobromide.Join the waitlist — get patent alerts
Track US2009156831A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.